Corneal Epithelial Damage in oGVHD

The cornea is the transparent front surface of the eye. Its outer layer, the corneal epithelium, protects the eye, supports clear vision, and contributes to comfort. In oGVHD, this surface can become fragile.

Corneal epithelial damage may develop when several protective systems fail at once. Tear production may decline. Tear-film quality may deteriorate. Blinking may become more abrasive. Eyelid inflammation may increase mechanical stress. Conjunctival disease may reduce mucin support. Inflammation may impair healing. These changes can create a hostile environment for the corneal surface.

The result may include punctate epithelial erosions, staining, epithelial defects, pain, foreign body sensation, tearing, light sensitivity, and fluctuating vision. In more severe cases, ocular GVHD can be associated with serious complications, including corneal ulceration, scarring, or perforation.

This is why corneal involvement deserves attention. The cornea is not only a window for vision. It is also a sensory structure. Surface breakdown can make ordinary tasks difficult: opening the eyes in the morning, reading, working on a screen, walking outside on a windy day, or tolerating bright light.

Corneal epithelial damage can also create a cycle. A damaged surface destabilizes the tear film. Tear instability increases exposure and friction. Exposure and friction worsen epithelial injury. Inflammation may continue. Symptoms become more disruptive. If the cycle is not interrupted, patients may experience chronic discomfort and functional impairment.

In oGVHD, clinicians may evaluate the cornea using slit-lamp examination, staining, tear testing, eyelid assessment, and related measures. These tools help determine whether symptoms reflect surface injury, tear deficiency, inflammation, eyelid disease, or a combination.

For patients, certain symptoms deserve prompt attention: significant pain, sudden vision change, worsening light sensitivity, redness, discharge, or difficulty keeping the eye open. These are not routine inconveniences. They may signal a more serious ocular surface problem.

For researchers, corneal epithelial health is a key domain in oGVHD. It can be measured, but no single test captures the full patient experience. A patient’s symptoms, staining pattern, visual fluctuation, epithelial integrity, and quality of life may each tell part of the story.

The cornea teaches a central lesson about oGVHD. The disease can affect both how the eye feels and how the patient sees.

Preserving the corneal epithelium is not merely about comfort. It is about maintaining ocular function.

This article is for educational purposes only and is not medical advice.

Sources:

1. Tappeiner C, Heiligenhaus A, Halter JP, et al. “Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease.” Frontiers in Medicine, 2023.
   https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1133381/full
2. Nassiri N, Eslani M, Panahi N, et al. “Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation.” Journal of Ophthalmic & Vision Research, 2013.
   https://pmc.ncbi.nlm.nih.gov/articles/PMC3957042/
3. Wolffsohn JS, Arita R, Chalmers R, et al. “TFOS DEWS II Diagnostic Methodology Report.” The Ocular Surface, 2017.
   https://www.tfosdewsreport.org/public/images/TFOS_DEWS_II_Diagnostic_method.pdf